Researchers in Australia have utilized artificial intelligence to create a protein that can effectively kill antibiotic-resistant bacteria such as E. coli.

This breakthrough presents a novel approach to combatting dangerous superbugs.

The study detailing this development has been published in the journal Nature Communications, as reported by ScienceDaily.

Dr. Rhys Grinter, one of the leading scientists overseeing the project, explained that traditionally, proteins for medical treatment are derived from nature with slight modifications.

However, advancements in AI training methods now allow for the creation of proteins "from scratch" with the desired properties, which will lower the costs and expedite the development of new drugs.

Previously, creating a specific protein for a particular disease could take researchers many years, while AI can accomplish this in mere seconds. Over the past year, it has developed numerous proteins that could later assist in treating a wide range of diseases, from snake bites to cancer.

An Australian team of biologists and computer specialists has created proteins that destroy antibiotic-resistant bacteria for the first time, offering new solutions in the fight against dangerous infections.

With the integration of AI, Australia now joins the ranks of the U.S. and China in having a platform capable of rapidly generating thousands of useful proteins, which could revolutionize healthcare in the country.

The AI protein development program operates at the Bio21 Institute of the University of Melbourne and the Monash Institute of Biomedical Discovery, led by Dr. Rhys Grinter and Associate Professor Gavin Nott.

They explain that their protein development platform is based on the principles of Nobel Laureate in Chemistry David Baker, who devised a method for creating a variety of proteins.

Associate Professor Nott adds, "These proteins are now being transformed into medications, vaccines, nanomaterials, tiny sensors, and other applications that are still undergoing testing.".